Theoretically, the inhibition of the upstream enzymes that are required to produce the toxic metabolite, such as inhibition of BCAT1 in methylmalonic acidemia, would provide an alternative method that is more feasible than preventing the intake of specific amino acids from the diet. This evidence concerns the gene BCAT1 and methylmalonic acidemia.